A Study of an Investigational Drug, ALN-AAT, in Healthy Adult Subjects and Patients With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease
Clinical trial NCT02503683 · TERMINATED
Trial details
- NCT number
- NCT02503683
- Sponsor
- Alnylam Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-09
- Primary completion
- 2018-01-03
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.